Liabilities / Assets
39th percentile
Higher debt load relative to assets than 39% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.04x
Liabilities / Revenue
24th percentile
Higher debt load relative to revenue than 24% of similar nonprofits.
Net Margin
80th percentile
Higher net margin than 80% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
75th percentile
Faster asset growth than 75% of similar nonprofits.
Revenue Growth
99th percentile
Faster revenue growth than 99% of similar nonprofits.
Balance Sheet
Assets
Up$404,401
Up $44,507 (+12%) from 2017
Net Assets
Up$387,969
Up $256,191 (+194%) from 2017
Liabilities
Down$16,432
Down $211,684 (-93%) from 2017
Revenue And Expenses
Revenue
Up$1,132,345
Up $975,344 (+621%) from 2017
Expenses
Up$875,726
Up $516,428 (+144%) from 2017
Net Income
Up$256,619
Up $458,916 (+227%) from 2017
Historical Trend
Filing Detail Status
This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview
Mission
Supports organizations and initiatives that improve the availability of vaccines, medicines and other healthcare products to those in need worldwide through a variety of educational and charitable activities, including those focused on pharmaceutical supply chain improvements.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2018 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $404,401
- Liabilities
- $16,432
- Net assets
- $387,969
- Revenue
- $1,132,345
- Expenses
- $875,726
- Net income
- $256,619